Kastus Technologies is a technology company.
Kastus Technologies has raised $12.0M across 3 funding rounds.
Kastus Technologies has raised $12.0M in total across 3 funding rounds.
Kastus Technologies has raised $12.0M in total across 3 funding rounds.
Kastus Technologies's investors include Atlantic Bridge, Glenn Solomon, ONSET Ventures, Rami Elkhatib.
# Kastus Technologies: High-Level Overview
Kastus is an Irish surface innovation company that develops photocatalytic antimicrobial and anti-soiling coatings for glass, ceramics, and metals.[1][2] Founded in 2014 and headquartered in Dublin, the company addresses two critical global challenges: antimicrobial resistance and solar panel efficiency degradation. Its core product is a visible light-activated coating technology that generates reactive oxygen species on treated surfaces, eliminating up to 99.99% of harmful bacteria and viruses—including coronavirus, MRSA, and E. coli—without toxic additives.[1][4] The technology is "always on" because it is fueled by ambient air moisture and light, and bacteria cannot develop resistance to its mechanism of action.[1]
Kastus serves multiple markets: healthcare and consumer electronics (antimicrobial touchscreens and surfaces), solar energy (anti-soiling coatings for photovoltaic panels), and industrial applications across glass and ceramics sectors. The company has achieved significant validation, holding 52 worldwide patents, 10 ISO validations, and 8 global certifications.[2] With a team of 12 employees and a client base spanning 30 countries, Kastus operates at a production capacity of 3,000 liters per day.[3] The company reported revenue of $5.8 million and has secured €5.6 million in funding to expand its commercial operations.[1]
# Origin Story
Kastus was founded in 2014 by John Browne, an entrepreneur with a vision to create "clean glass technologies" that would benefit society and the environment.[2] The founding emerged from recognition of two interconnected problems: the growing threat of antimicrobial resistance in healthcare and contaminated surfaces, and the efficiency losses caused by soiling on solar panels. Rather than pursuing a single market, Browne built a platform technology applicable across multiple industries.
The company's early development was supported by Atlantic Bridge (a venture capital firm), which funded the technology from Technology Readiness Level (TRL) 3 to TRL 8.[4] This backing enabled Kastus to move from laboratory research into commercial-scale production. A pivotal moment came when the company's antimicrobial coating was validated to kill human coronavirus, leading to partnerships with consumer electronics brands like InvisibleShield for screen protection products.[1] The company subsequently secured EU funding through the SPYGLASS project to accelerate the transition to full production capacity and expand into touchscreen and broader glass antimicrobial markets.[4]
# Core Differentiators
# Role in the Broader Tech Landscape
Kastus operates at the intersection of three converging trends: the global antimicrobial resistance crisis, the accelerating adoption of renewable energy, and heightened demand for hygiene solutions post-pandemic. The company's timing is strategic—healthcare systems worldwide are desperate for non-toxic, non-chemical solutions to surface contamination, while solar energy providers seek cost-effective ways to maintain panel efficiency in dusty or humid climates.
The broader materials science and coatings industry is shifting toward sustainable, passive technologies that reduce reliance on chemical treatments and frequent maintenance. Kastus exemplifies this shift by offering a "set and forget" solution that works for the lifetime of the product. The company's success influences how other coating manufacturers approach antimicrobial challenges, potentially accelerating industry-wide adoption of photocatalytic approaches over traditional antimicrobial additives.
Additionally, Kastus's EU funding and international patent portfolio position it as a European technology leader in a space increasingly dominated by Asian manufacturers, helping establish Ireland as a hub for advanced materials innovation.
# Quick Take & Future Outlook
Kastus is well-positioned for significant growth as antimicrobial resistance becomes a more urgent public health priority and solar energy deployment accelerates globally. The company's forecasted revenues for 2025 exceeded €42 million according to its EU funding application, suggesting aggressive scaling plans.[4] Key challenges ahead include scaling manufacturing capacity, penetrating competitive markets dominated by established coatings companies, and navigating regulatory approval processes across different geographies and applications.
The company's next phase will likely focus on commercializing its solar anti-soiling applications—a massive addressable market as renewable energy capacity expands—while deepening penetration in healthcare and consumer electronics. Success will depend on whether Kastus can maintain its technological edge while building the sales and distribution infrastructure needed to compete globally. If the company executes on its growth trajectory, it could become a defining player in sustainable surface technologies, proving that passive, chemistry-free solutions can outperform traditional approaches across multiple industries.
Kastus Technologies has raised $12.0M across 3 funding rounds. Most recently, it raised $7.0M Series A in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2021 | $7.0M Series A | Atlantic Bridge, Glenn Solomon, ONSET Ventures, Rami Elkhatib | |
| Aug 1, 2018 | $3.0M Series A | Atlantic Bridge, Glenn Solomon, ONSET Ventures, Rami Elkhatib | |
| Nov 1, 2016 | $2.0M Seed | Atlantic Bridge, Glenn Solomon, ONSET Ventures, Rami Elkhatib |